CFTR corrector 9
CAS No. 909861-78-5
CFTR corrector 9( —— )
Catalog No. M35450 CAS No. 909861-78-5
CFTR Corrector 9, a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, is employed in the research of cystic fibrosis (CF) and related CFTR-associated disorders .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 62 | Get Quote |
|
| 5MG | 92 | Get Quote |
|
| 10MG | 147 | Get Quote |
|
| 25MG | 288 | Get Quote |
|
| 50MG | 431 | Get Quote |
|
| 100MG | 606 | Get Quote |
|
| 500MG | 1251 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCFTR corrector 9
-
NoteResearch use only, not for human use.
-
Brief DescriptionCFTR Corrector 9, a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, is employed in the research of cystic fibrosis (CF) and related CFTR-associated disorders .
-
DescriptionCFTR corrector 9 (compound 42) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. CFTR corrector 9 can be used for researching cystic fibrosis (CF) and other CFTR associated disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCFTR
-
RecptorCFTR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number909861-78-5
-
Formula Weight298.29
-
Molecular FormulaC16H14N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (419.06 mM; Ultrasonic (<80°C)
-
SMILESCOc1cccc(c1)-c1cc(no1)C(=O)NCc1ccco1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bradley Tait, et al. Methods of modulating cftr activity. WO2014210159A1
molnova catalog
related products
-
Ataluren
PTC124 (Ataluren) selectively induces ribosomal read-through of premature but not normal termination codons, with EC50 of 0.1 μM.
-
WAY-326766
WAY-326766 increases ion transport through mutant CFTR and can be used to alter the lifespan of eukaryotes.WAY-326766 can be used to treat cystic fibrosis (CF).
-
FDL169
FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation.
Cart
sales@molnova.com